Abcam to Acquire BioVision for $340 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. CRGY
5. ZETA
6. SPY
7. RMR
8. DVN
9. GOOG
10. GOOGL

Go back to Abcam to Acquire BioVision for $340 million

Abcam plc (ABCM) Acquires BioVision for $340M

August 2, 2021 5:48 AM EDT

Abcam plc (Nasdaq: ABCM) today announces that it has entered into a definitive agreement to acquire BioVision, Inc. ("BioVision"), a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. (NKY), for $340 million (the Acquisition).

Transaction highlights

BioVision is a fast-growing innovator and distributor of life science research tools to biopharma, diagnostic and academic customers, with strength in biochemical and cell-based assay kitsBrings one of Abcams large third-party suppliers... More